Skip to main content
. 2025 Mar 21;104(12):e41911. doi: 10.1097/MD.0000000000041911

Table 3.

MR analysis and sensitivity analyses for causality from upper urinary stones on 12 blood metabolites

Name Outcome Metabolites Number of SNPs MR analysis Heterogeneity Pleiotropy MR-PRESSO
Method OR (95% CI) Lower CI Upper CI P IVW MR Egger Intercept P P
Q P Q P
1-methyl-4-imidazoleacetate GCST90199717 Azoles 55 IVW 1.03 0.98 1.09 0.2144 53.45 0.4954 53.27 0.4638 ‐0.0031 0.6695 0.2175
Mannose GCST90200435 Carbohydrate 55 IVW 1.06 1.00 1.13 0.0449 66.38 0.1202 66.33 0.1033 0.0018 0.8325 0.1154
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) GCST90200073 Lipid 55 IVW 0.96 0.91 1.01 0.1403 53.69 0.4864 53.69 0.4478 0.0002 0.9787 0.1449
Eicosenedioate (C20:1-DC) GCST90200285 Lipid 55 IVW 1.02 0.96 1.08 0.5097 53.53 0.4923 51.73 0.5237 0.0101 0.1850 0.5107
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) GCST90200065 Lipid 55 IVW 1.04 0.99 1.10 0.1236 51.11 0.5867 51.07 0.5495 0.0013 0.8596 0.1193
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) GCST90200331 Lipid 55 IVW 1.05 0.99 1.11 0.1123 56.21 0.3921 56.07 0.3604 0.0028 0.7197 0.1182
1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) GCST90200079 Lipid 55 IVW 1.00 0.95 1.05 0.9470 49.11 0.6629 49.11 0.6263 -0.0004 0.9565 0.9447
Adenosine 5’-monophosphate (AMP) GCST90200356 Nucleotide 55 IVW 0.98 0.93 1.03 0.4519 55.80 0.4070 55.79 0.3704 -0.0007 0.9217 0.4552
Cysteinylglycine GCST90200364 Peptide 55 IVW 0.98 0.93 1.03 0.4040 48.16 0.6981 47.92 0.6716 -0.0036 0.6306 0.3808
Urea GCST90200417 Ureas 55 IVW 1.05 0.99 1.11 0.1282 63.49 0.1768 63.34 0.1563 0.0027 0.7306 0.1341
X-17654 GCST90200547 Unknown 55 IVW 0.97 0.92 1.02 0.2403 40.55 0.9123 40.54 0.8951 -0.0004 0.9547 0.1811
X-19141 GCST90200711 Unknown 55 IVW 1.00 0.94 1.05 0.8769 48.62 0.6811 48.47 0.6511 0.0029 0.6936 0.2175

CI = confidence interval, IVW = inverse variance weighted, MR = Mendelian randomization, MR-PRESSO = MR-Pleiotropy RESidual sum and outlier, OR = odds ratio, SNPs = single nucleotide polymorphisms.